Related Experiment Videos
Carbamazepine-induced nonepileptic myoclonus in a child with benign epilepsy
U Aguglia1, M Zappia, A Quattrone
1Institute of Neurological Sciences, Faculty of Medicine, University of Reggio Cal., Catanzaro, Italy.
Insights
Carbamazepine (CBZ) can cause nonepileptic myoclonus and tics in children with epilepsy. These involuntary movements resolved upon CBZ withdrawal, indicating a potential adverse effect unrelated to seizure activity.
Area of Science:
- Neurology
- Pediatric Epilepsy
- Pharmacology
Background:
- Benign occipital epilepsy is a common childhood epilepsy syndrome.
- Carbamazepine (CBZ) is a widely used antiepileptic drug.
- Involuntary movements can be challenging to differentiate from seizure activity in pediatric epilepsy.
Observation:
- An 11-year-old boy with benign occipital epilepsy presented with myoclonic jerks and tic-like movements.
- These movements emerged during treatment with carbamazepine (CBZ).
- The involuntary movements resolved upon CBZ discontinuation and recurred upon reintroduction.
Findings:
- Polygraphic studies showed no electroencephalogram (EEG) changes during the myoclonic jerks, suggesting a nonepileptic origin.
- Plasma CBZ levels remained within the therapeutic range throughout the observation period.
- The involuntary movements were attributed to carbamazepine (CBZ) as an adverse effect.
Implications:
- The emergence of nonepileptic myoclonus in epileptic children on CBZ requires careful evaluation.
- Differentiating drug-induced involuntary movements from seizure exacerbation is crucial for appropriate management.
- The presence of coexisting tics may aid in diagnosing carbamazepine (CBZ)-induced nonepileptic myoclonus.
Abstract:
Myoclonic jerks involving the proximal limb musculature and tic-like movements (sniffing, coughing, or sighing) were observed in an 11-year-old boy with benign occipital epilepsy treated with carbamazepine (CBZ). The involuntary movements disappeared a few days after withdrawal of CBZ and reappeared with CBZ reintroduction. Plasma CBZ levels were always within the therapeutic range. Polygraphic studies failed to show any electroencephalogram (EEG) changes during myoclonic jerks. Appearance of nonepileptic myoclonus in epileptic children treated with CBZ should be carefully evaluated to prevent worsening of the clinical picture. The coexistence of other involuntary movements (tics) could suggest the correct diagnosis.